Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.

Rubinstein PG, Chen YH.

Am J Hematol. 2008 Aug;83(8):684-5. doi: 10.1002/ajh.21201. No abstract available.

2.

Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.

Christopher K, Horkan C, Barb IT, Arbelaez C, Hodgdon TA, Yodice PC.

Am J Hematol. 2004 Nov;77(3):299-302.

3.

Intravenous Rh immune globulin for treating immune thrombocytopenic purpura.

Sandler SG.

Curr Opin Hematol. 2001 Nov;8(6):417-20. Review. Erratum in: Curr Opin Hematol 2002 Mar;9(2):179.

PMID:
11604585
4.

Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.

Golla S, Horkan C, Dogaru G, Teske TE, Christopher K.

Acta Haematol. 2008;120(2):100-3. doi: 10.1159/000165693. Epub 2008 Oct 29.

PMID:
18957844
5.
6.

A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).

Tarantino MD, Bussel JB, Cines DB, McCrae KR, Gernsheimer T, Liebman HA, Wong WY, Kulkarni R, Grabowski E, McMillan R.

Blood. 2007 Jun 15;109(12):5527; author reply 5528. No abstract available.

7.

Severe hemolysis following administration of Rh(o)(D) immune globulin in an ITP patient associated with anti-C.

Schwartz J, Spitalnik S, Grima KM.

Blood. 2006 Mar 15;107(6):2585. No abstract available.

8.

Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.

Levendoglu-Tugal O, Jayabose S.

J Pediatr Hematol Oncol. 2001 Oct;23(7):460-3.

PMID:
11878583
9.
10.

Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.

Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ; Acute ITP Study Group.

J Pediatr. 2006 Apr;148(4):489-94.

PMID:
16647411
11.

Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent.

Berger-Achituv S, Ellis MH, Curtis BR, Wolach B.

Am J Hematol. 2008 Aug;83(8):676-8. doi: 10.1002/ajh.21185.

12.

What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?

Garratty G.

Transfusion. 2009 Jun;49(6):1026-31. doi: 10.1111/j.1537-2995.2009.02216.x. No abstract available. Erratum in: Transfusion. 2009 Aug;49(8):1774.

PMID:
19638151
13.

Comparison of intravenous immunoglobulin and high dose anti-D immunoglobulin as initial therapy for childhood immune thrombocytopenic purpura.

Ozsoylu S.

Br J Haematol. 2011 Mar;152(6):783-4. doi: 10.1111/j.1365-2141.2010.08435.x. Epub 2011 Jan 30. No abstract available.

PMID:
21275947
14.

Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.

Kane I, Ragucci D, Shatat IF, Bussel J, Kalpatthi R.

Br J Haematol. 2010 Apr;149(1):79-83. doi: 10.1111/j.1365-2141.2009.08057.x. Epub 2010 Jan 20.

PMID:
20096011
15.

Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.

Alioglu B, Avci Z, Ozyurek E, Ozbek N.

J Pediatr Hematol Oncol. 2007 Sep;29(9):636-9.

PMID:
17805040
16.

Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura.

Kees-Folts D, Abt AB, Domen RE, Freiberg AS.

Pediatr Nephrol. 2002 Feb;17(2):91-6. Review.

PMID:
11875670
17.

Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.

Kumar M, Vik TA, Johnson CS, Southwood ME, Croop JM.

Am J Hematol. 2005 Mar;78(3):181-7.

18.

Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.

Ramadan KM, El-Agnaf M.

Clin Lab Haematol. 2005 Aug;27(4):267-9. Review.

PMID:
16048495
19.

Management of adult idiopathic thrombocytopenic purpura.

Nakhoul IN, Kozuch P, Varma M.

Clin Adv Hematol Oncol. 2006 Feb;4(2):136-44, 153. Review.

PMID:
16728922
20.

Cerebral venous thrombosis after immune thrombocytopenic purpura and anti-D immune globulin therapy.

Kayyali HR, Abdelmoity AT, Morriss MC, Graf WD.

J Child Neurol. 2008 Mar;23(3):325-30. doi: 10.1177/0883073807309251. Epub 2008 Jan 9.

PMID:
18184936

Supplemental Content

Support Center